Castle Biosciences Shows TissueCypher Improves Barrett’s Care
Phoenix, Arizona, September 15, 2026 Castle Biosciences has announced findings from a new decision-modeling study showing that its TissueCypher...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Phoenix, Arizona, September 15, 2026 Castle Biosciences has announced findings from a new decision-modeling study showing that its TissueCypher...
NANJING, China, August 3, 2026 Leads Biolabs announced that the Center for Drug Evaluation (CDE) of China’s National Medical...
CULVER CITY, Calif., July 28, 2026 Avenda Health announced that its FDA-cleared Unfold AI platform is now being used...
Boston and Tel Aviv, Israel, July 23, 2026 Ibex Medical Analytics announced it has received CE-IVDR certification for Ibex...
